In the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the first significant advancement in ocular drug delivery methods in over a century.
Read Press ReleaseThe Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers
Read Press ReleaseDespite what one may think, contact lens users do not have to give in to the wearing of half eyes, bifocals, or reading glasses. The good news is that they can continue enjoying the benefits of contacts by switching to multi-focals.
Read Press Release